Jesus Corral

发表

Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer and EGFR-Activating Mutations.

Xiangdong Zhou, Maria Rita Migliorino, Kazuhiko Nakagawa, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.